Study Evaluating Efficacy and Safety of Crisaborole in Adults With Stasis Dermatitis
Clinical trial NCT04091087 · COMPLETED
Trial details
- NCT number
- NCT04091087
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-26
- Primary completion
- 2021-10-19
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.